ProCure Secures $35 Million in Private Equity Financing

ProCure Treatment Centers, Inc., which is developing a network of cancer treatment centers across the United States to deliver FDA approved proton radiotherapy, today announced it has received a $35 million equity investment from Oklahoma City-based McClendon Venture Company, LLC and several related individuals in Oklahoma City, including Shannon T. Self and John B. Frick. MVC is owned by Aubrey K. McClendon, co-founder, Chairman and Chief Executive Officer of Chesapeake Energy Corporation.

The funding will be used to facilitate ProCure’s plans to develop and operate a national network of specialized proton therapy centers to treat cancer patients. The closing of this round of equity financing has occurred less than five weeks after ProCure unveiled plans to construct its first four-room, 55,000 SF treatment center in Oklahoma City.

Was this article helpful?

Related Articles

Leave A Comment?